www.mediafax.ro/sanatate/pilula-testata-de-un-an-s

Daraxonrasib has shown promising results in treating advanced pancreatic cancer, with 90% of patients experiencing halted tumor growth. This daily pill may reduce or eliminate tumors in some cases. However, experts caution that these findings are preliminary and not a cure. The drug targets RAS mutations common in pancreatic cancers, potentially benefiting other cancer types as well. While results are encouraging, further studies are needed to determine long-term effectiveness and remission duration.

Fact-check this story: paste the text or link into Justificat.ro and get a verdict with the sources consulted.